Akzo Nobel reacted to the fourth quarter figures on Tuesday with significant sales.
Akzo Nobel shares recently lost 5.5 percent. JPMorgan analysts pointed to adjusted operating profit (Ebitda) that was below consensus estimates in the fourth quarter. The outlook for the current year also appears conservative.
Bernstein said that weak growth is currently masking management’s efforts to reduce costs. The focus of interest at the moment is the merger with Axalta.
/mf/jha/
AMSTERDAM (dpa-AFX)
Image sources: Akzo Nobel NV
